Patents by Inventor Amani Alhalwani

Amani Alhalwani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11957737
    Abstract: Methods of treating or preventing microbial infection in a subject in need of treatment by administering a therapeutically effective amount of ergothioneine, or functional analog, or prodrug, or salt thereof. Ergothioneine may be advantageously administered in conjunction with lactoferrin.
    Type: Grant
    Filed: June 30, 2022
    Date of Patent: April 16, 2024
    Assignees: COLORADO SEMINARY, OWNER AND OPERATOR OF UNIVERSITY OF DENVER, THE REGENTS OF THE UNIVERSITY OF COLORADO
    Inventors: John Repine, Amani Alhalwani
  • Publication number: 20220362349
    Abstract: Methods of treating or preventing microbial infection in a subject in need of treatment by administering a therapeutically effective amount of ergothioneine, or functional analog, or prodrug, or salt thereof. Ergothioneine may be advantageously administered in conjunction with lactoferrin.
    Type: Application
    Filed: June 30, 2022
    Publication date: November 17, 2022
    Inventors: John Repine, Amani Alhalwani
  • Patent number: 11376311
    Abstract: Methods of treating or preventing microbial infection in a subject in need of treatment by administering a therapeutically effective amount of ergothioneine, or functional analog, or prodrug, or salt thereof. Ergothioneine may be advantageously administered in conjunction with lactoferrin.
    Type: Grant
    Filed: November 1, 2018
    Date of Patent: July 5, 2022
    Assignees: COLORADO SEMINARY, OWNER AND OPERATOR OF UNIVERSITY OF DENVER, THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
    Inventors: John Repine, Amani Alhalwani
  • Publication number: 20200261548
    Abstract: Methods of treating or preventing microbial infection in a subject in need of treatment by administering a therapeutically effective amount of ergothioneine, or functional analog, or prodrug, or salt thereof. Ergothioneine may be advantageously administered in conjunction with lactoferrin.
    Type: Application
    Filed: November 1, 2018
    Publication date: August 20, 2020
    Inventors: John Repine, Amani Alhalwani